In summary, CLDN-1 is expressed in all preneoplastic lesions of colonic adenocarcinoma, including SSA/P, MVHP, APC mutations, adenomatous polyps, and inflammatory bowel disease (Table 1 and Table 2). This evidence concerns the gene CLDN1 and colon adenocarcinoma.